Immunocytokine with target cell-restricted IL-15 activity for treatment of acute lymphoblastic leukemia (ALL)

被引：0
|
作者：
Hagelstein, I [1 ,2 ]
Zekri, L. [1 ,2 ]
Klimovich, B. [1 ,2 ]
Lutz, M. S. [1 ,2 ]
Greve, C. [3 ]
Maerklin, M. [1 ,2 ]
Mueller, S. [1 ,2 ]
Schmied, B. J. [1 ,2 ]
Jung, G. [3 ]
Salih, H. R. [1 ,2 ]
机构：
[1] Univ Hosp Tubingen, Dept Internal Med, German Canc Consortium DKTK, Clin Collaborat Unit Translat Immunol, Tubingen, Germany
[2] Univ Tubingen, Cluster Excellence iFIT EXC2180 Image Guided & Fu, Tubingen, Germany
[3] Eberhard Karls Univ Tubingen, Dept Immunol, Tubingen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V281
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] A CD135 immunocytokine with target cell-restricted IL-15 activity for treatment of AML
    Lutz, Martina S.
    Schmied, Bastian J.
    Riegg, Fabian
    Zekri, Latifa
    Heitmann, Jonas S.
    Maerklin, Melanie
    Pfluegler, Martin
    Jung, Gundram
    Salih, Helmut R.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies
    Zekri, Latifa
    Hagelstein, Ilona
    Maerklin, Melanie
    Klimovich, Boris
    Christie, Mary
    Lindner, Cornelia
    Kaemereit, Sofie
    Prakash, Nisha
    Mueller, Stefanie
    Stotz, Sophie
    Maurer, Andreas
    Greve, Carsten
    Schmied, Bastian
    Atar, Daniel
    Rammensee, Hans-Georg
    Jung, Gundram
    Salih, Helmut R.
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (737)
  • [3] Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies
    Hagelstein, Ilona
    Zekri, Latifa
    Klimovich, Boris
    Lutz, Martina S.
    Greve, Carsten
    Mueller, Stefanie
    Maerklin, Melanie
    Schmied, Bastian
    Jung, Gundram
    Salih, Helmut R.
    CANCER RESEARCH, 2022, 82 (12)
  • [4] Targeting acute myeloid leukemia (AML) for NK cell immunity using immunocytokines with target cell-restricted IL-15 activity
    Schmied, B. J.
    Doerfel, D.
    Maerklin, M.
    Zekri, L.
    Pfluegler, M.
    Kanz, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 233 - 233
  • [5] Immunocytokines with Target Cell-Restricted IL-15 Activity for Induction of NK Cell Reactivity Against Acute Myeloid Leukemia (AML)
    Schmied, Bastian J.
    Zekri, Latifa
    Pfluegler, Martin
    Maerklin, Melanie
    Kanz, Lothar
    Jung, Gundram
    Salih, Helmut R.
    BLOOD, 2018, 132
  • [6] A CLEC12A immunocytokine with target cell-restricted IL-15 activity shows a favorable toxicity profile and high potency in AML
    Klimovich, Boris
    Anton, Leonard
    Lim, Yangmi
    Won, Jonghwa
    Chashchina, Anna
    Pflugler, Martin
    Zekri, Latifa
    Jung, Gundram
    Salih, Helmut R.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] MIC12, a CLEC12A-immunocytokine with target cell-restricted IL-15 activity limits side effects and mediates potent efficacy in AML
    Klimovich, B.
    Anton, L.
    Lim, Y.
    Won, J.
    Chashchina, A.
    Pfluegler, M.
    Zekri, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 35 - 35
  • [8] Anti-CD19 immunocytokine with target cell restricted IL15 activity
    Zekri, L.
    Lindner, C.
    Pfluegler, M.
    Salih, H. R.
    Jung, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 129 - 129
  • [9] CD133/FLT3 immunocytokines with target cell-restricted IL-15 activity for induction of NK cell immunity against AML
    Schmied, B. J.
    Maerklin, M.
    Zekri-Metref, L.
    Pflugler, M.
    Kanz, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 9 - 9
  • [10] IL-15 as a potential target in leukemia
    Xiong, Yu
    Bensoussan, Daniele
    Decot, Veronique
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2015, 5 : 55 - 63
12345